Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition

Cardiac fibrosis is an important pathological process of diabetic cardiomyopathy, the underlying mechanism remains elusive. This study sought to identify whether inhibition of Myocyte enhancer factor 2A (MEF2A) alleviates cardiac fibrosis by partially regulating Endothelial-to-mesenchymal transition...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xue-ying, Lv, Rui-juan, Zhang, Wei, Yan, Yu-gang, Li, Peng, Dong, Wen-qian, Liu, Xue, Liang, Er-shun, Tian, Hong-liang, Lu, Qing-hua, Zhang, Ming-xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058738/
https://www.ncbi.nlm.nih.gov/pubmed/27105518
http://dx.doi.org/10.18632/oncotarget.8842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058738/
https://www.ncbi.nlm.nih.gov/pubmed/27105518
http://dx.doi.org/10.18632/oncotarget.8842

Ejemplares similares